![](https://www.fdanews.com/ext/resources/test/Device_Images3/Koning_Logo.gif?t=1433997939&width=430)
Koning Gets FDA Green Light for 3D Breast Imaging System
Medical imaging systems maker Koning said Wednesday that the FDA approved its 3D Koning Breast CT imaging system and KBCT-guided biopsy bracket.
The KBCT is the first 3D breast CT scanner commercially available in the U.S. that images the entire breast with a single scan, according to the Rochester, N.Y., devicemaker. The rapid procedure acquires hundreds of images in 10 seconds, with excellent patient comfort that avoids compressing breast tissue.
Optional accessories include a biopsy bracket to enable KBCT-guided biopsies of suspicious lesions and a collimator used to limit the x-ray beam to the area of interest. The biopsy bracket delivers 3D targeting at comparable or lower radiation rates compared with stereotactic-guided biopsy, the company said.
Premarket approval was based on more than 680 patient scans. — Kellen Owings